US Patent Issued to Guangzhou Yufan Nantu Biotechnologies on March 24 for "IRAK4 kinase inhibitor and preparation method therefor" (Chinese Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,582,650, issued on March 24, was assigned to Guangzhou Yufan Nantu Biotechnologies Co. Ltd (Guangzhou, China).

"IRAK4 kinase inhibitor and preparation method therefor" was invented by Xingyu Lin (Guangdong, China) and Tingting Lu (Guangdong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a compound of general formula I, and a pharmaceutically acceptable salt, a stereoisomer, an ester, a prodrug, a solvate and a deuterated compound thereof, wherein the compound is an IRAK4 kinase inhibitor, and can be used for preventing and/or treating diseases related to IRAK4, such as autoimmune diseases, inflammatory diseases, ca...